These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36478458)

  • 1. Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Zhang Z; Yu K; Jiang Z; Liu O; Wan C; Wu H; Cao X
    J Dermatol; 2023 Apr; 50(4):518-524. PubMed ID: 36478458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
    J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
    Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
    JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.
    Suo H; Jiang B; Sun X; Dong J; Alamgir M; Guan X; Su H; Liu Y; Xia Y; Zhou N; Feng A; Tao J
    Dermatology; 2022; 238(4):736-744. PubMed ID: 34875648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Duplisea MJ; Roberson ML; Chrisco L; Strassle PD; Williams FN; Ziemer CM
    J Am Acad Dermatol; 2021 Oct; 85(4):873-877. PubMed ID: 33940101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of histologic features of toxic epidermal necrolysis.
    Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
    J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
    Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
    J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Zhang L; Lan Y; Qi B; Shuai P; Hou Q; Liu W; Wang Q
    Allergy Asthma Immunol Res; 2023 Nov; 15(6):812-824. PubMed ID: 37957797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Tian XB; Liu W; Zhang LX
    J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Torres-Navarro I; Briz-Redón Á; Botella-Casas G; Sahuquillo-Torralba A; Calle-Andrino A; de Unamuno-Bustos B; Piqueras-García J; Roca Ginés J; Magdaleno Tapial J; Alegre de Miquel V; Botella-Estrada R
    J Dermatol; 2020 Oct; 47(10):1182-1186. PubMed ID: 32856355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
    Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
    Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients.
    Rattanakaemakorn P; Palakornkitti P; Pinyowiwat P; Jedee P; Thadanipon K
    Front Med (Lausanne); 2022; 9():939210. PubMed ID: 36091688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.
    Morsy H; Taha EA; Nigm DA; Shahin R; Youssef EMK
    Clin Exp Dermatol; 2017 Dec; 42(8):868-873. PubMed ID: 28940568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute graft-versus-host disease presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study.
    Hung YT; Chen YW; Huang Y; Lin YJ; Chen CB; Chung WH
    J Am Acad Dermatol; 2023 Apr; 88(4):792-801. PubMed ID: 36280000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.